Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 1,412,700 | 1,385,800 | 1,354,400 | 1,369,400 | 1,329,900 |
| Cost of Goods | 301,600 | 292,200 | 262,900 | 275,500 | 286,900 |
| Gross Profit | 1,111,100 | 1,093,600 | 1,091,500 | 1,093,900 | 1,043,000 |
| Operating Expenses | 716,900 | 781,200 | 741,800 | 727,900 | 694,900 |
| Operating Income | 394,800 | 312,600 | 350,600 | 366,500 | 349,000 |
| Other Income | 39,100 | 77,500 | 52,200 | 17,500 | 22,200 |
| Pre-tax Income | 433,900 | 390,100 | 402,800 | 384,000 | 371,200 |
| Income Tax | 70,300 | 45,100 | 40,700 | 20,000 | 46,300 |
| Net Income Continuous | 363,600 | 345,000 | 362,100 | 364,000 | 324,900 |
| Net Income Discontinuous | -7,200 | 39,300 | 2,707,300 | 1,000 | 26,100 |
| Minority Interests | -1,600 | -1,300 | -1,400 | -1,300 | -900 |
| Net Income | $358,000 | $385,600 | $3,070,800 | $366,300 | $351,900 |
| EPS Basic Total Ops | 0.61 | 0.65 | 5.14 | 0.61 | 0.58 |
| EPS Basic Continuous Ops | 0.62 | 0.58 | 0.61 | 0.61 | 0.54 |
| EPS Basic Discontinuous Ops | -0.01 | 0.07 | 4.53 | 0.00 | 0.04 |
| EPS Diluted Total Ops | 0.61 | 0.65 | 5.13 | 0.61 | 0.58 |
| EPS Diluted Continuous Ops | 0.62 | 0.58 | 0.61 | 0.61 | 0.54 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.07 | 4.52 | 0.00 | 0.04 |
| EPS Diluted Before Non-Recurring Items | 0.64 | 0.59 | 0.67 | N/A | N/A |
| EBITDA(a) | $431,400 | $355,200 | $385,100 | $406,100 | $387,500 |